ES2170788T3 - Procedimiento para la obtencion de inmunoglobulinas a partir de fracciones que resultan de plasma sanguineo humano. - Google Patents
Procedimiento para la obtencion de inmunoglobulinas a partir de fracciones que resultan de plasma sanguineo humano.Info
- Publication number
- ES2170788T3 ES2170788T3 ES95810596T ES95810596T ES2170788T3 ES 2170788 T3 ES2170788 T3 ES 2170788T3 ES 95810596 T ES95810596 T ES 95810596T ES 95810596 T ES95810596 T ES 95810596T ES 2170788 T3 ES2170788 T3 ES 2170788T3
- Authority
- ES
- Spain
- Prior art keywords
- immunoglobulin
- obtaining
- procedure
- blood plasma
- plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—DNA viruses
- C07K16/082—Hepadnaviridae (F), e.g. hepatitis B virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Gram-positive bacteria
- C07K16/1282—Clostridium (G)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE OBTIENEN PREPARADOS DE INMUNOGLOBULINA DE ALTA VALORACION, LLEVANDO A CABO SUCESIVAMENTE LOS SIGUIENTES PASOS: - FRACCIONAMIENTO DE PLASMA SANGUINEO A PARTIR DE UN CONJUNTO DE PLASMA, MEDIANTE EL CUAL SE SEPARA AL MENOS LA FRACCION DE VALOR INDUSTRIAL, QUE CONTIENE ESENCIALMENTE LA INMUNOGLOBULINA G POLICLONAL, OBTENIENDO AL MENOS UNA FRACCION RESIDUAL, - OBTENCION DE UNA SOLUCION PROTEINICA A PARTIR DE LOS COMPONENTES PROTEINICOS QUE ESTAN CONTENIDOS EN LA FRACCION RESIDUAL OBTENIDA EN EL PASO A) O EN SUBFRACCIONES DE ELLA, Y - AL MENOS UNA ETAPA DE CROMATOGRAFIA DE AFINIDAD CON LA SOLUCION PROTEINICA RESULTANTE CON LIGANDOS INMOVILIZADOS DE AL MENOS UN TIPO DE LIGANDO, DISOLVIENDO LAS PROTEINAS PLASMATICAS ESPECIFICAMENTE UNIDAS Y PASANDOLAS COMO COMPONENTES ACTIVOS A UN PREPARADO DE INMUNOGLOBULINA DE ALTA VALORACION. LAS INMUNOGLOBLINAS OBTENIDAS SE PUEDEN PROCESAR PARA DAR UN PRODUCTO ESTABLE. EL PROCEDIMIENTO, QUE OBTIENE UN PREPARADO VALIOSO DE INMUNOGLOBULINA, UTILIZA FRACCIONESPLASMATICAS HUMANAS, QUE SE DESECHABAN HASTA AHORA EN PROCEDIMIENTO CONVENCIONALES E INDUSTRIALES DE FRACCIONAMIENTO DE PLASMA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95810596A EP0764658B1 (de) | 1995-09-22 | 1995-09-22 | Verfahren zur Gewinnung von Immunglobulinen aus Fraktionen, die bei der Fraktionierung von menschlichem Blutplasma entstehen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2170788T3 true ES2170788T3 (es) | 2002-08-16 |
Family
ID=8221797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95810596T Expired - Lifetime ES2170788T3 (es) | 1995-09-22 | 1995-09-22 | Procedimiento para la obtencion de inmunoglobulinas a partir de fracciones que resultan de plasma sanguineo humano. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0764658B1 (es) |
| JP (1) | JP2952572B2 (es) |
| KR (1) | KR100236762B1 (es) |
| CN (1) | CN1089609C (es) |
| AT (1) | ATE211486T1 (es) |
| AU (1) | AU715427B2 (es) |
| BR (1) | BR9603826A (es) |
| CA (1) | CA2185617A1 (es) |
| CZ (1) | CZ286885B6 (es) |
| DE (1) | DE59509979D1 (es) |
| DK (1) | DK0764658T3 (es) |
| ES (1) | ES2170788T3 (es) |
| FI (1) | FI963719A7 (es) |
| HU (1) | HUP9602570A3 (es) |
| MX (1) | MX9604256A (es) |
| NO (1) | NO963952L (es) |
| NZ (1) | NZ299394A (es) |
| PL (1) | PL316126A1 (es) |
| PT (1) | PT764658E (es) |
| RO (1) | RO117921B1 (es) |
| RU (1) | RU2157240C2 (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2531459A1 (es) * | 2013-06-10 | 2015-03-16 | Antonio VILA SANJURJO | Método para la separación física de "traductomas" convolucionados |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1293119B1 (it) * | 1997-06-12 | 1999-02-11 | Mini Ricerca Scient Tecnolog | Processo per la separazione di immunoglobuline specifiche da plasma standard e loro utilizzo per trattamenti terapeutici |
| US6159471A (en) * | 1997-10-23 | 2000-12-12 | Yoshitomi Pharmaceutical Industries, Ltd. | Room temperature storable immunoglobulin preparation for intravenous injection |
| RU2239453C2 (ru) * | 2002-12-03 | 2004-11-10 | Федеральное государственное унитарное предприятие " Научно-производственное объединение по медицинским иммунобиологическим препаратам " Микроген" | Препарат иммуноглобулина человека против цитомегаловируса и способ его получения |
| RU2252780C1 (ru) * | 2004-04-30 | 2005-05-27 | Аваков Анатолий Эдуардович | Способ получения иммуноглобулинового препарата |
| MX2007002085A (es) * | 2004-08-20 | 2007-07-19 | Prometic Biosciences Ltd | Esquemas de aislamiento y purificacion consecutivos de proteinas mediante cromatografia de afinidad. |
| DE102005023155A1 (de) * | 2005-05-13 | 2006-11-16 | Albutec Gmbh | Albuminlösung |
| EP2233499A1 (en) | 2009-03-26 | 2010-09-29 | CSL Behring AG | Antibody composition with altered Fab sialylation |
| US20100322943A1 (en) * | 2009-06-17 | 2010-12-23 | Thomas Cantor | Therapeutic and diagnostic affinity purified specific polyclonal antibodies |
| ITRM20090558A1 (it) * | 2009-11-03 | 2011-05-04 | Michele Pitaro | Procedimento per la produzione di immunoglobuline estratte da plasma umano ad uso terapeutico neutralizzanti il virus di epstein barr e farmaco contenente dette immunoglobuline |
| GB201006753D0 (en) | 2010-04-22 | 2010-06-09 | Biotest Ag | Process for preparing an immunolobulin composition |
| SG187599A1 (en) * | 2010-07-23 | 2013-03-28 | Baxter Int | Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma |
| FR3018450B1 (fr) * | 2014-03-11 | 2016-04-15 | Lab Francais Du Fractionnement | Procede de preparation de proteines plasmatiques humaines |
| KR20150115639A (ko) * | 2014-04-04 | 2015-10-14 | 전숙영 | 치료용 면역글로불린 제제 제조에 사용되는 산성 완충액, 이를 이용한 치료용 면역글로불린 제제 제조방법 및 이 제조방법으로 제조된 치료용 면역글로불린 제제 |
| GB201413227D0 (en) * | 2014-07-25 | 2014-09-10 | Bioproducts Lab Ltd | Process |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4232004A (en) * | 1977-09-21 | 1980-11-04 | American National Red Cross | Antibody-specific solid phase immunoadsorbent, preparation thereof, and antibody purification therewith |
| US4617379A (en) * | 1983-06-14 | 1986-10-14 | Miles Laboratories, Inc. | High titer cytomegalovirus immune serum globulin |
| DE3516119A1 (de) * | 1985-05-04 | 1986-11-06 | Biotest Pharma GmbH, 6000 Frankfurt | Polyvalentes hyperimmunglobulin-praeparat |
| IL90281A (en) * | 1988-06-06 | 1994-10-07 | Miles Inc | Preparations containing MGI antibodies |
-
1995
- 1995-09-22 AT AT95810596T patent/ATE211486T1/de not_active IP Right Cessation
- 1995-09-22 DK DK95810596T patent/DK0764658T3/da active
- 1995-09-22 PT PT95810596T patent/PT764658E/pt unknown
- 1995-09-22 EP EP95810596A patent/EP0764658B1/de not_active Expired - Lifetime
- 1995-09-22 DE DE59509979T patent/DE59509979D1/de not_active Expired - Lifetime
- 1995-09-22 ES ES95810596T patent/ES2170788T3/es not_active Expired - Lifetime
-
1996
- 1996-09-16 NZ NZ299394A patent/NZ299394A/en unknown
- 1996-09-16 CA CA002185617A patent/CA2185617A1/en not_active Abandoned
- 1996-09-18 PL PL96316126A patent/PL316126A1/xx unknown
- 1996-09-18 CZ CZ19962748A patent/CZ286885B6/cs not_active IP Right Cessation
- 1996-09-18 KR KR1019960040589A patent/KR100236762B1/ko not_active Expired - Fee Related
- 1996-09-19 AU AU65725/96A patent/AU715427B2/en not_active Ceased
- 1996-09-19 HU HU9602570A patent/HUP9602570A3/hu unknown
- 1996-09-19 FI FI963719A patent/FI963719A7/fi unknown
- 1996-09-19 RO RO96-01839A patent/RO117921B1/ro unknown
- 1996-09-20 NO NO963952A patent/NO963952L/no unknown
- 1996-09-20 BR BR9603826A patent/BR9603826A/pt active Search and Examination
- 1996-09-21 CN CN96122771A patent/CN1089609C/zh not_active Expired - Fee Related
- 1996-09-23 RU RU96118916/14A patent/RU2157240C2/ru not_active IP Right Cessation
- 1996-09-23 MX MX9604256A patent/MX9604256A/es unknown
- 1996-09-24 JP JP8251895A patent/JP2952572B2/ja not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2531459A1 (es) * | 2013-06-10 | 2015-03-16 | Antonio VILA SANJURJO | Método para la separación física de "traductomas" convolucionados |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0764658A1 (de) | 1997-03-26 |
| CA2185617A1 (en) | 1997-03-23 |
| HU9602570D0 (en) | 1996-11-28 |
| NZ299394A (en) | 1997-12-19 |
| PL316126A1 (en) | 1997-04-01 |
| CN1153063A (zh) | 1997-07-02 |
| AU715427B2 (en) | 2000-02-03 |
| HUP9602570A2 (en) | 1997-08-28 |
| BR9603826A (pt) | 1998-06-02 |
| EP0764658B1 (de) | 2002-01-02 |
| JP2952572B2 (ja) | 1999-09-27 |
| HUP9602570A3 (en) | 1998-01-28 |
| ATE211486T1 (de) | 2002-01-15 |
| RU2157240C2 (ru) | 2000-10-10 |
| CZ274896A3 (en) | 1997-04-16 |
| JPH09124508A (ja) | 1997-05-13 |
| NO963952L (no) | 1997-03-24 |
| CZ286885B6 (en) | 2000-07-12 |
| CN1089609C (zh) | 2002-08-28 |
| NO963952D0 (no) | 1996-09-20 |
| FI963719A0 (fi) | 1996-09-19 |
| AU6572596A (en) | 1997-04-10 |
| MX9604256A (es) | 1998-04-30 |
| DE59509979D1 (de) | 2002-02-07 |
| RO117921B1 (ro) | 2002-09-30 |
| KR100236762B1 (ko) | 2000-01-15 |
| DK0764658T3 (da) | 2002-04-22 |
| KR970015745A (ko) | 1997-04-28 |
| FI963719A7 (fi) | 1997-03-23 |
| PT764658E (pt) | 2002-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2170788T3 (es) | Procedimiento para la obtencion de inmunoglobulinas a partir de fracciones que resultan de plasma sanguineo humano. | |
| Plummer et al. | The isolation of ribonuclease B, a glycoprotein, from bovine pancreatic juice | |
| ES2032802T3 (es) | Sucedaneo de la sangre, semisintetico, extrapuro. | |
| ATE72121T1 (de) | Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen. | |
| NO900529D0 (no) | Separering av plasmaproteiner ved hjelp av kromatografering. | |
| Garrick et al. | Rat haemoglobin heterogeneity. Two structurally distinct α chains and functional behaviour of selected components | |
| Givol et al. | The C-terminal peptide of the heavy chain of the rabbit immunoglobulin IgG | |
| AU4667399A (en) | Fractionation process | |
| ES2031849T3 (es) | Procedimiento para la preparacion de un concentrado del factor v. | |
| ATE516715T1 (de) | Ernährungszusammensetzung zur behandlung von dekubitalgeschwüren | |
| UA29421C2 (uk) | Спосіб виділення фактора vііі з інших білків в плазмі крові | |
| DK1985634T3 (da) | Antistofbindende p-selectin glycoprotein-ligand 1 (PSGL-1) til anvendelse i behandling af en allergisk sygdom | |
| AU3137699A (en) | Novel process for the separation of proteins using a Ca ++ containing eluant | |
| Guisasola et al. | Plasmin digestion of factor VIII: characterization of the breakdown products with respect to antigenicity and von Willebrand activity | |
| Rhodes et al. | Composition of egg phospholipids | |
| DE59913850D1 (de) | Verfahren zur Trennung von glykosylierten und nicht-glykosylierten Proteinen | |
| Frankling et al. | Paper chromatography of protein mixtures and blood plasmas | |
| Estborn et al. | Localisation of acid phosphatase by starch-gel electrophoresis of fractionally collected human semen | |
| FI93696B (fi) | Kymotrypsiinin käyttö prekallikreiini-aktivaattorin tehottamiseksi tekemiseksi | |
| Nyyssönen et al. | Comparison of gel permeation chromatography, density gradient ultracentrifugation and precipitation methods for quantitation of very-low-, low-and high-density lipoprotein cholesterol | |
| Meissner | The Oedipus complex and the paranoid process. | |
| FR2623628B1 (fr) | Serum etalon, de nature humaine, reconstitue a partir des fractions rejetees (non utilisees en therapeutique), du fractionnement du plasma humain, du sang humain, du sang placentaire ou retroplacentaire | |
| AU2001282251A1 (en) | Lipo-viro-particle complexes, preparation method and uses | |
| RU96111854A (ru) | Способ получения иммуноглобулинов | |
| S'iakste | Interaction of various nuclear matrix proteins with DNA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 764658 Country of ref document: ES |